James Crowe
Director, Vanderbilt Vaccine Center · Pediatric Infectious Diseases-Vanderbilt University Medical Center
Credentials: · ·
History
PresentVanderbilt Vaccine Center · Pediatric Infectious Diseases-Vanderbilt University Medical Center
PresentVanderbilt Vaccine Center · Vanderbilt Univ Sch of Med
- 2024–Present
Residency in Pediatrics-University of North Carolina Chapel Hill
Research
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature · 2020 · 901 citations
Cell Host & Microbe · 2021 · 834 citations
Nature Medicine · 2021 · 800 citations
67 papers
- JW
25 papers
23 papers
20 papers
- JB
14 papers · 2 as a fellow
- TS
12 papers
9 papers
9 papers
Grants
- 2025–2030
Machine Learning to Modulate Influenza Immunity
National Institute of Allergy and Infectious Diseases · U01
PI · $2.4M · Vanderbilt University
- 2007–2029
Antibody-Based Protection Against Flaviviruses
National Institute of Allergy and Infectious Diseases · U01
PI · $3.3M · Washington University
- 2024–2027
Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $38.1M · Vanderbilt University Medical Center
- 2024–2027
Flavivirus and Alphavirus ReVAMPP (FLARE)
National Institute of Allergy and Infectious Diseases · U19
Project lead · $5.6M · Washington University
Clinical trials
- 2017–2020